INSIGHTS ON DRUG DEVELOPMENT

• Fast And Accurate Detection Of Alzheimer's Disease Targets

  In this study, the detection of three Alzheimer’s disease targets are highlighted: Human BDNF (Brain-derived neurotrophic factor), Tau, and TREM2 (Triggering receptor expressed on myeloid cells 2).

• Modeling Inflammation-Specific Immune Cell Recruitment

  Traditional models for studying inflammatory bowel disease (IBD) often fall short. See how the Colon Intestine-Chip was used to model the progression of IBD driven by immune cells more completely.

• Quantification Of Semaglutide With A Reliable Analytical Method

  Explore a validated LC-MS/MS method for precise Semaglutide quantification in plasma, which features enhanced sensitivity, peak definition, and reproducibility using innovative technologies.

• Using Affinity Chromatography For The Purification Of Lentiviral Particles

  This new affinity chromatography resin offers an efficient and scalable purification method for lentiviral particles in combination with gentle elution conditions to retain viral infectivity.

• A Simple Method For Cell Growth Media Preparation

  11/3/2025

  Explore how powder media and sterile fluid handling can reduce contamination risk and improve efficiency in viral vector production, especially for HEK293-based AAV workflows.

• Aggregate Analysis Of Semaglutide

  12/11/2025

  Effective size exclusion chromatography (SEC) for Semaglutide aggregate analysis is possible without high organic solvents or acidic modifiers. Learn about this robust method for improved efficacy.

• Neuroinflammation In Alzheimer's Disease Pathway

  3/24/2025

  Recent research highlights neuroinflammation's role in AD progression, which suggests immune modulation as a potential therapeutic strategy. Learn more about neuroinflammatory processes in AD pathology.

• Glucagon-Like Peptide-1 (GLP-1) Analogues Applications Notebook

  12/11/2025

  View this collection of application notes about the chromatographic analysis and purification of GLP-1 analogues, including Semaglutide, Tirzepatide, Liraglutide, and Exenatide.

• A Holistic Approach To Understanding High And Low HEK293 Producer

  4/4/2025

  Despite advancements in AAV-based gene therapy, key aspects of AAV biology and production remain unclear. Find out how researchers are exploring HEK293 subclones to identify traits that enhance viral vector yields.